CorticoMetrics is a privately-held company founded in 2012 as a spin-off from the Martinos Center for Biomedical Imaging at Massachusetts General Hospital. They work with MGH in research and product development through NIH grant-funded projects. Their team has extensive experience in neuroimaging and computing technology industries. CorticoMetrics targets neurological disorders like epilepsy, dementia, multiple sclerosis, traumatic brain injury, and hydrocephalus, and their goal is to augment qualitative assessment with quantitative analysis of MRI scans to improve clinical decision making in neuroradiology.